Cataract Clinical Trial
Official title:
Refractive Outcomes Evaluation of the Verion Image Guided System + ORA System With VerifEye
NCT number | NCT02513745 |
Other study ID # | CEP 2014-003 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2015 |
Est. completion date | May 5, 2017 |
Verified date | January 2019 |
Source | Carolina Eyecare Physicians, LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Nowadays cataract patient's expectations are closer to those of refractive surgery patients.
Patients want to be spectacle independent. However, fifteen to twenty percent of cataract
surgery patients have from 1.00 to 3.00 diopters (D) of corneal astigmatism which makes
achieving spectacle independence unlikely in this patients unless the astigmatism is treated
at the time of cataract surgery. Option to treat this astigmatism include corneal or limbal
incisions (LRIs), the use of toric intraocular lenses (IOLs) or LASIK. Regardless of the
treatment of choice to correct the astigmatism at time of cataract extraction, a treatment
plan has to be calculated preoperatively. This planning include: keratometry measurements and
the use of a calculator to estimate the treatment and orientation of IOL and/or placement of
the LRIs.
New technology has been developed and is widely used. Among this technology, we have the
VERION Image Guided System. This system encompasses a reference unit that takes a picture of
the eye with the patient in the sitting position creating image of the patient's eye,
capturing scleral vessels, limbus and iris features. It measures keratometry as well as the
corneal diameter (limbus) and pupil size. The information captured is transferred
automatically to its planner where IOL power calculation and astigmatism correction
calculation are completed. Additionally, intraoperative wavefront aberrometry has been used
in the last couple of years with increase success.
Status | Completed |
Enrollment | 84 |
Est. completion date | May 5, 2017 |
Est. primary completion date | May 5, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - Subject is undergoing bilateral cataract extraction or refractive lens exchange with intraocular lens implantation and astigmatism correction. - Willing and able to provide written informed consent for participation in the study - Willing and able to comply with scheduled visits and other study procedures. Exclusion Criteria: - Severe preoperative ocular pathology: amblyopia, rubella cataract, proliferative diabetic retinopathy, shallow anterior chamber, macular edema, retinal detachment, aniridia or iris atrophy, uveitis, history of iritis, iris neovascularization, medically uncontrolled glaucoma, microphthalmos or macrophthalmos, optic nerve atrophy, macular degeneration (with anticipated best postoperative visual acuity less than 20/30), advanced glaucomatous damage, etc. - Uncontrolled diabetes. - Use of any systemic or topical drug known to interfere with visual performance. - Contact lens use during the active treatment portion of the trial. - Any concurrent infectious/non infectious conjunctivitis, keratitis or uveitis. - Pseudoexfoliation syndrome or any other condition that has the potential to weaken the zonules - Previous refractive surgery. - Any clinically significant, serious or severe medical or psychiatric condition that may increase the risk associated with study participation or study device implantation or may interfere with the interpretation of study results. - Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial. - Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye. |
Country | Name | City | State |
---|---|---|---|
United States | Carolina Eyecare Physicians, LLC | Mount Pleasant | South Carolina |
Lead Sponsor | Collaborator |
---|---|
Carolina Eyecare Physicians, LLC | Science in Vision |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Residual Refractive Cylinder | This is the manifest refractive cylinder measured 3 months after surgery. Note that because cataract surgery has been performed, there is no associated baseline value. | Three months | |
Secondary | Residual Mean Spherical Equivalent Refraction | This is the mean of the spherical equivalent refraction (sphere + 0.5*cylinder) from each eye. Note that because cataract surgery has been performed, there is no associated baseline value. | Three months | |
Secondary | Residual Corneal Astigmatism | This is the anterior corneal astigmatism measured through keratometry. Note that because cataract surgery has been performed, there is no associated baseline value. | Three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |